Quote Spy AVII NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.



Enter Tickers





   Avi Biopharma (AVII)
 
Click the portfolio to add AVII:
Close [X]
+ Add AVII to Portfolio
Last Trade: 1.46 -0.09 (-5.81%) @ 4:00 PM

3-Month Chart (Larger chart w/volume)

Close [X]

1m  3m  6m  1y  2y 
Volume: 1,038,007 Avg Volume: 1,540,000
Day's Range: 1.45 - 1.55 52-wk Range: 0.45 - 2.73
Open: 1.54 Market Cap: 126.7M
Previous Close: 1.55 P/E: -4.6
Bid: 1.45 x 40 Div Yield: $0.00 (0.00%)
Ask: 1.47 x 9    
Spy AVII
To see which Pros and tickerspy members own AVII Sign up now
Indexes
Swine Flu and Bird Flu Stocks (-0.4%)
Additional AVII resources



Customize Links
Latest AVII Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

To start a new thread post a Link or Note and tag it AVII
Chasing Value: Ten stocks for 2010 -- Part 3
GBE  AVII  ETFC  AOB  
Linked by BloggingStocks - November 16, 01:40PM from (www.bloggingstocks.com)
In this installment of our search for the ten picks for 2010, I will risk my reputation (and money) as I head in a more speculative  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
AVII  
Linked by marketwire - November 09, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today reported financial results for the three and nine  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
AVII  
Linked by marketwire - November 02, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will hold a conference call to report third quarter 2009  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Fortunes Being Made in Small-Cap Pharmaceutical Stocks
AVII  STEM  HDIX  MNKD  DEPO  OPXA  CUR  OSIR  
Linked by tickerspy blog - October 05, 10:43AM from (www.tickerspy.com)
Small-cap drug makers are making breakthroughs left and right in 2009.


Menlo Park, California-based DepoMed  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
China's Vaccine Approval Sends Flu Stocks Soaring
VICL  AVII  APT  HEB  DVAX  SVA  NVS  GSK  
Linked by tickerspy blog - August 31, 12:43PM from (www.tickerspy.com)
Flu news from China has driven the market higher over the last week, today sending stocks up by as much as 30%.

 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
avii, right or wrong
AVII  
Posted by rosewater - August 27, 07:02PM
I've taken a large position, relatively speaking on this company, and want to know what's going on. At first I bought it  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI Biopharma Misses Q2 View By 21c
AVII  
Linked by StreetInsider - August 10, 10:44AM from (www.streetinsider.com)
AVI Biopharma (Nasdaq: AVII) reports Q2 EPS of ($0.23), 21 cents below the analyst estimate of ($0.02).  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Second Quarter 2009 Financial Results & Corporate Highlights
AVII  
Linked by marketwire - August 10, 08:00AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today reported financial results for the three and six  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AVI BioPharma Announces Second Quarter 2009 Financial Results Conference Call
AVII  
Linked by marketwire - August 03, 08:01AM from (www2.marketwire.com)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will hold a conference call to report second quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5


 



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource